Wentworth Kory James's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Dec 3, 2024
- Accession no.
- 0001689375-24-000068
- Filed
- Dec 3, 2024
- Trade date
- Nov 29-Dec 2, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $120.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wentworth Kory JamesCIK 0001725663 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseAcquired | +1,000 | $2.10 | +$2,100 | 74,849 | Direct | |
| Nov 29, 2024 | Common Stock | SSaleDisposed | −1,000 | $19.97 | −$19,970 | 73,849 | Direct | |
| Dec 2, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $2.10 | +$10,500 | 78,849 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −5,000 | $20.00 | −$100,000 | 73,849 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseDisposed | −1,000 | $0.00 | $0 | 36,157 | Direct | |
| Dec 2, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 31,157 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.